Cambrium brings novel molecules with previously unseen functionalities to life, through a technology platform which combines biology and machine learning to supercharge product innovation. With its new class of sustainable, high-performance molecules, Cambrium is transforming the paradigm of toxic petrochemicals and unethical animal ingredients currently found in a staggering majority of consumer products.
Protein ingredients are applied in many industries. With a focus on Cosmetics & Personal care, Fashion, and Nutraceuticals, Cambrium can serve a $24.6 billion market in total.
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Mitchell Duffy
CEO and Co-Founder
HOW IT WORK
The Science
To decarbonize industries, next-generation sustainable materials must replace conventional, resource-intensive alternatives. Cambrium’s technology platform combines biology, machine learning, and generative AI to design and optimize novel protein molecules for sustainable product innovation.
Cambrium harnesses microbes, not mines; fermentors, not factory farms; and proteins, not petrochemicals. Its flagship product, NovaColl™, is the first micro-molecular, skin-identical collagen, specifically designed for high-efficacy skincare formulations. Unlike traditional collagen extracted from animals, NovaColl™ is produced through precision fermentation, offering a bio-compatible, ethical, and sustainable alternative.
EARTH FIRST VISION
The Future
Cambrium is unlocking the next generation of bio-based materials by leveraging biology’s molecular building blocks to redefine the products we use everyday. Utilizing AI-driven molecular programmability of proteins and precision fermentation, Cambium is transforming sustainable and high-performance products across industries, from personal care to fashion and packaging.
The global protein ingredient industry is valued at $61 billion, with a projected annual growth rate of 7%. Protein ingredients in cosmetics and personal care alone account for $4.9 billion. Cambrium is tapping into a high-growth sector with diverse applications in nutritional and functional ingredients, developing novel bio-based alternatives that are better for people, and the planet.
people
Their DNA
Founded in 2022, Cambrium is a Berlin-based startup driven by an interdisciplinary team of business strategists, materials scientists, molecular biologists and machine learning specialists committed to reinventing materials at the molecular level. Mitchell Duffy, PhD (Co-founder & CEO), holds degrees in Biology & Computer Science (Tufts University), Synthetic Biology (Imperial College London), and Molecular Imaging (University of Münster). Charlie Cotton, PhD (Co-founder & CSO), is an expert in structural biology, with a Biochemistry degree from Cambridge, a PhD from Imperial College London, and postdoctoral research at the Max Planck Institutes.